Litcius/Paper detail

The Application of Seaweed Polysaccharides and Their Derived Products with Potential for the Treatment of Alzheimer’s Disease

Sarah Bauer, Weihua Jin, Fuming Zhang, Robert J. Linhardt

2021Marine Drugs70 citationsDOIOpen Access PDF

Abstract

Neurodegenerative diseases are among the most widespread diseases affecting humans, and the number of patients is only rising. Seaweed polysaccharide extracts show significant neuroprotective and reparative activities. Seaweed polysaccharides might provide the next big breakthrough in neurodegenerative disease treatment. This paper reviews the applications of seaweed polysaccharides as potential treatments of neurodegenerative diseases. The particular focus is on fucoidan, ulvan, and their derivatives as potential agents to treat Alzheimer's disease. This review provides a critical update on the progress in this important research area.

Topics & Concepts

FucoidanDiseasePolysaccharideDisease treatmentNeuroprotectionBrown seaweedAlzheimer's diseaseBiologyBiotechnologyTraditional medicineMedicineAlgaePharmacologyBiochemistryBotanyPathologySeaweed-derived Bioactive CompoundsMacrophage Migration Inhibitory FactorBiochemical effects in animals
The Application of Seaweed Polysaccharides and Their Derived Products with Potential for the Treatment of Alzheimer’s Disease | Litcius